Grimm, Jan
4 papers on CoChatORCID 0000-0002-3898-3298
Most cited papers
- Verified
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 3,059
- Verified
NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss
Tackenberg, C., Grinschgl, S., Trutzel, A., Santuccione, A. C., Frey, M. C., Konietzko, U., Grimm, J., Brandt, R., & Nitsch, R. M. (2013) · Cell Death & Disease
Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research
Cited by 130
- Verified
Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro
Nobuhara, C. K., DeVos, S. L., Commins, C., Wegmann, S., Moore, B. D., Roe, A. D., Costantino, I., Frosch, M. P., Pitstick, R., Carlson, G. A., et al. (2017) · The American Journal of Pathology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 120
- Verified
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2017) · Nature
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 83
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free